Emetine regulates the alternative splicing of caspase 9 in tumor cells

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1309-1312

  Pan, Danmin ^a   Boon Unge, Kritsanapol ^b,c   Govitrapong, Piyarat ^b   Zhou, Jianhua ^a,c  

^a NANTONG UNIVERSITY   (China)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alternative splicing; Caspase 9; Emetine

Indexed keywords

CALYCULIN A; CASPASE 9; EMETINE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; EXON; HUMAN; HUMAN CELL; PROSTATE CANCER;

EID: 80052708840     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.395     Document Type: Article

References (19)

1. Mercatante D and Kole R: Modification of alternative splicing pathways as a potential approach to chemotherapy. Pharmacol Ther 85: 237-243, 2000.
2. Black DL: Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell 103: 367-370, 2000.
3. Graveley BR: Alternative splicing: increasing diversity in the proteomic world. Trends Genet 17: 100-107, 2001.
4. Goldstrohm AC, Greenleaf AL and Garcia-Blanco MA: Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 277: 31-47, 2001.
5. Caceres JF and Kornblihtt AR: Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 18: 186-193, 2002.
6. Modrek B and Lee C: A genomic view of alternative splicing. Nat Genet 30: 13-19, 2002.
7. Krawczak M, Reiss J and Cooper DN: The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90: 41-54, 1992.
8. Schwerk C and Schulze-Osthoff K: Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell 19: 1-13, 2005.
9. Johnson CR and Jarvis WD: Caspase-9 regulation: an update. Apoptosis 9: 423-427, 2004.
10. Moore MJ, Wang Q, Kennedy CJ and Silver PA: An alternative splicing network links cell-cycle control to apoptosis. Cell 142: 625-636,
11. Chalfant CE, Rathman K, Pinkerman RL, et al: De novo ceramide regulates the alternative splicing of caspase9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 277: 12587-12595, 2002.
12. Massiello A and Chalfant CE: SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness. J Lipid Res 47: 892-897, 2006.
13. Merdzhanova G, Edmond V, De Seranno S, et al: E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell Death Differ 15: 1815-1823, 2008.
14. Grollman AP: Inhibitors of protein biosynthesis. V. Effects of emetine on protein and nucleic acid biosynthesis in He La cells. J Biol Chem 243: 4089-4094, 1968.
15. Boon-Unge K, Yu Q, Zou T, Zhou A, Govitrapong P and Zhou J: Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism. Chem Biol 14: 1386-1392, 2007.
16. Jondorf WR, Abbott BJ, Greenberg NH and Mead JA: Increased lifespan of leukemic mice treated with drugs related to (-)-emetine. Chemotherapy 16: 109-129, 1971.
17. Johnson RK and Jondorf WR: Some inhibitory effects of (--)-emetine on growth of Ehrlich ascites carcinoma. Biochem J 140: 87-94, 1974.
18. Panettiere F and Coltman CA Jr: Experience with emetine hydrochloride (NSC 33669) as an antitumor agent. Cancer 27: 835-841, 1971.
19. Siddiqui S, Firat D and Olshin S: Phase II study of emetine (NSC-33669) in the treatment of solid tumors. Cancer Chemother Rep 57: 423-428, 1973.